Detection and Monitoring of Serum P53 Antibodies in Patients With Colorectal Cancer.

Gut - United Kingdom
doi 10.1136/gut.40.3.356
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Serum Expression of Β-Catenin Is a Potential Detection Marker in Patients With Colorectal Cancer

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2019English

Detection of Mutant K-Ras DNA in Plasma or Serum of Patients With Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
1997English

Serum Concentrations of Soluble Adhesion Molecules in Patients With Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
1998English

Serum Anti-P53 Antibody as a Tumour Marker for Colorectal Cancer Screening

ecancermedicalscience
Cancer ResearchOncology
2015English

Optimal Sequences and Combination of Chemotherapy and Monoclonal Antibodies in the Treatment of Patients With Metastatic Colorectal Cancer

Malignant tumours
2018English

Conversion Analysis for Mutation Detection in MLH1 and MSH2 in Patients With Colorectal Cancer

JAMA - Journal of the American Medical Association
Medicine
2005English

Colorectal Cancer Patients Exhibit Increased Levels of Galanin in Serum and Colon Tissues

Oncology Letters
Cancer ResearchOncology
2016English

ArhGAP30 Promotes P53 Acetylation and Function in Colorectal Cancer

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2014English

A Retrospective Analysis of Plasma Concentration Monitoring of Fluorouracil in Patients With Advanced Colorectal Cancer

European Journal of Hospital Pharmacy: Science and Practice
Pharmacy
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy